Clinical Trials

21 studies in Oncology in Minnesota

  1. A Phase II Clinical Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
    1. Minnesota
  2. A Phase 1b Study of LY2835219 in Combination With Endocrine Therapies for Patients With Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
    1. Minnesota
  3. Randomized, Open Label, Phase 2 Study of MM-111 and Paclitaxel With Trastuzumab in Patients With HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach Who Have Failed Front Line Metastatic or Locally Advanced Therapy
    1. Minnesota
  4. A Randomized, Open-Label Phase 2 Study Evaluating LY2875358 Plus Erlotinib and LY2875358 Monotherapy in MET Diagnostic Positive NSCLC Patients With Acquired Resistance to Erlotinib
    1. Arizona,
    2. Minnesota
  5. Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett s Esophagus Compared With Standard Endoscopy
    1. Minnesota
  6. Phase 1 Dose Finding Study of Belinostat Plus Cyclophosphamide/Vincristine/Doxorubicin/Prednisone (CHOP) Regimen (BelCHOP) for Treatment of Patients With Peripheral T-cell Lymphoma(PTCL)
    1. Minnesota
  7. Clinical Trials - Mayo Clinic Research
    1. Minnesota
  8. A Phase II Trial of HKI-272 (Neratinib) for Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer and Brain Metastases
    1. Minnesota
  9. A Phase II Study For The Treatment Of Non-Metastatic Nodular Desmoplastic Medulloblastoma In Children Less Than 4 Years Of Age
    1. Minnesota
  10. Evaluating the Impact of 18F-DOPA-PET on Neurosurgical Planning for Gliomas
    1. Minnesota
  1. 1
  2. 2
  3. 3
  4. Next